Key Developments: Syngenta AG (SYT)

SYT on New York Consolidated

68.88USD
24 Apr 2015
Change (% chg)

$0.43 (+0.63%)
Prev Close
$68.45
Open
$68.87
Day's High
$69.10
Day's Low
$68.67
Volume
132,772
Avg. Vol
--
52-wk High
$79.85
52-wk Low
$58.72

Search Stocks

Latest Key Developments (Source: Significant Developments)

Syngenta AG gives FY 2014, 2015 revenue outlook - Conference Call
Wednesday, 5 Feb 2014 02:30pm EST 

Syngenta AG:Expects FY 2014 sales growth for the integrated business at constant exchange rates to be similar to the 6 pct achieved in FY 2013.Expects acceleration of sales growth in FY 2015 to be within a range of 22 pct to 24 pct, albeit at the lower end.The company reported revenue of $14.688 bln in FY 2013.FY 2014 revenue of $15.639 bln - Thomson Reuters I/B/E/S.FY 2015 revenue of $16.679 bln - Thomson Reuters I/B/E/S.  Full Article

Isagro SpA Enters into Commercial Agreement with Syngenta AG for Supply and Distribution of Copper Fungicide BADGE WG
Tuesday, 3 Sep 2013 12:20pm EDT 

Isagro SpA announced that it has entered into an agreement with Syngenta AG for the supply and distribution of BADGE WG, a copper based fungicide, in a number of European countries. BADGE WG is a patented formulation of copper oxychloride and copper hydroxide which combines the technical advantages of two different copper salts, providing control of downy mildew and other fungal and bacterial diseases of grapes, fruit trees and vegetables at lower rate of application; BADGE WG is also approved for use in organic farming. This agreement will grant Isagro access to the marketing and distribution network of Syngenta. Syngenta, will undertake the distribution of BADGE WG on an exclusive basis in: Austria, Bulgaria, Czech Republic, France, Germany, Greece, Hungary, Poland, Portugal, Romania, Slovakia and Slovenia and will operate as non-exclusive distributor in Italy and Spain. In few selected countries Syngenta will distribute BADGE WG under its own trademark. Further terms of the commercial agreement were not disclosed.  Full Article

Syngenta AG To Challenge EU Suspension Of Bee Crop Chemical-DJ
Tuesday, 27 Aug 2013 01:05am EDT 

Dow Jones reported that Syngenta AG said it has submitted a legal challenge to the European Commission's decision to suspend the use of thiamethoxam on bee attractive crops. The Commission took the decision on the basis of a flawed process, an inaccurate and incomplete assessment by the European Food Safety Authority and without the full support of EU Member States, Syngenta said. Syngenta called on all stakeholders to concentrate on practical solutions to bee health, which experts agree is damaged by disease, viruses and the loss of habitat and nutrition.  Full Article

Syngenta AG Reaffirms FY 2013 Revenue Guidance-Conference Call
Friday, 26 Jul 2013 01:00am EDT 

Syngenta AG announced that for fiscal 2013, it expects sales growth in line with long-term target of 8%. The Company reported revenue of $14.202 billion in fiscal 2012. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $15.06 billion for fiscal 2013.  Full Article

Syngenta AG To Acquire African Corn Seed Business
Tuesday, 2 Jul 2013 03:30pm EDT 

Syngenta AG announced that it will acquire MRI Seed Zambia Ltd and MRI Agro Ltd (MRI), a developer, producer and distributor of white corn seed in Zambia. The transaction is subject to regulatory approvals and is expected to close by the end of 2013. No financial details were disclosed.  Full Article

MDL Watch: Syngenta, Xarelto and Fresenius suits see gains in April

- A Reuters' analysis of statistics from the U.S. Judicial Panel on Multidistrict Litigation showed the biggest increases in recent filings over Syngenta genetically modified corn, Bayer and Janssen's blood thinner Xarelto and dialysis drugs made by Fresenius.

Search Stocks